Enhanced Proofreading Governs CRISPR-Cas9 Targeting Accuracy
Janice S. Chen(Mammoth Biosciences (United States)), Jennifer A. Doudna(University of California, Berkeley), Keith Joung(Harvard University), Yavuz S. Dagdas(University of California, Berkeley), Samuel H. Sternberg(University of California, Berkeley), Moira M. Welch(Massachusetts General Hospital), Lucas B. Harrington(Mammoth Biosciences (United States)), Alexander A. Sousa(Broad Institute), Ahmet Yıldız(University of California, Berkeley), Benjamin P. Kleinstiver(Harvard University)
Cited by 20
Related Papers
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
|Science|2018|4.4k
CRISPR–Cas12-based detection of SARS-CoV-2
|Nature Biotechnology|2020|2.8k
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
|Nature|2016|2.7k
RNA-programmed genome editing in human cells
|eLife|2013|2.1k